201 related articles for article (PubMed ID: 11148566)
1. Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma.
Yuen MF; Wu PC; Lai VC; Lau JY; Lai CL
Cancer; 2001 Jan; 91(1):106-12. PubMed ID: 11148566
[TBL] [Abstract][Full Text] [Related]
2. Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun, and c-myc proto-oncogenes: role of cellular calcium and reactive oxygen species.
Joseph P; Muchnok TK; Klishis ML; Roberts JR; Antonini JM; Whong WZ; Ong T
Toxicol Sci; 2001 Jun; 61(2):295-303. PubMed ID: 11353138
[TBL] [Abstract][Full Text] [Related]
3. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins.
Li H; Xie P; Li G; Hao L; Xiong Q
Toxicon; 2009 Jan; 53(1):169-75. PubMed ID: 19041662
[TBL] [Abstract][Full Text] [Related]
4. DNA damage, apoptosis and C-myc, C-fos, and C-jun overexpression induced by selenium in rat hepatocytes.
Yu RA; Yang CF; Chen XM
Biomed Environ Sci; 2006 Jun; 19(3):197-204. PubMed ID: 16944776
[TBL] [Abstract][Full Text] [Related]
5. Gene expression in skin tumors induced in hairless mice by chronic exposure to ultraviolet B irradiation.
Sato H; Suzuki JS; Tanaka M; Ogiso M; Tohyama C; Kobayashi S
Photochem Photobiol; 1997 May; 65(5):908-14. PubMed ID: 9155265
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.
Volm M
Anticancer Res; 1993; 13(2):375-8. PubMed ID: 8100127
[TBL] [Abstract][Full Text] [Related]
7. Selective induction of c-jun and jun-B but not c-fos or c-myc during mitogenesis in SV40-transformed cells at the predifferentiation growth arrest state.
Wang H; Wang JY; Johnson LR; Scott RE
Cell Growth Differ; 1991 Dec; 2(12):645-52. PubMed ID: 1667087
[TBL] [Abstract][Full Text] [Related]
8. Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc.
Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
[TBL] [Abstract][Full Text] [Related]
9. The Differential Immunohistochemical Expression of p53, c-Jun, c-Myc, and p21 Between HCV-related Hepatocellular Carcinoma With and Without Cirrhosis.
Abdou AG; Abd-Elwahed M; Badr M; Helmy M; Soliman EA; Maher D
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):75-87. PubMed ID: 25710583
[TBL] [Abstract][Full Text] [Related]
10. EGF promotes development of a differentiated trophoblast phenotype having c-myc and junB proto-oncogene activation.
Dakour J; Li H; Chen H; Morrish DW
Placenta; 1999 Jan; 20(1):119-26. PubMed ID: 9950153
[TBL] [Abstract][Full Text] [Related]
11. Expression of early genes in estrogen induced phenotypic conversion of neuroblastoma cells.
Santagati S; Ma ZQ; Ferrarini C; Pollio G; Maggi A
J Neuroendocrinol; 1995 Nov; 7(11):875-9. PubMed ID: 8748125
[TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin.
Kakar SS; Roy D
Cancer Lett; 1994 Nov; 87(1):85-9. PubMed ID: 7954373
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.
Ikeguchi M; Hirooka Y
Pathobiology; 2004; 71(5):281-6. PubMed ID: 15459488
[TBL] [Abstract][Full Text] [Related]
14. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
15. Nuclear oncogenes and alpha-fetoprotein gene expression in hepatoma cell lines.
Tournier-Thurneyssen I; Feldmann G; Bernuau D
Tumour Biol; 1993; 14(4):201-12. PubMed ID: 7692587
[TBL] [Abstract][Full Text] [Related]
16. Effect of Qi-protecting powder (Huqi San) on expression of c-jun, c-fos and c-myc in diethylnitrosamine-mediated hepatocarcinogenesis.
Li X; Shi ZM; Feng P; Wen ZY; Wang XJ
World J Gastroenterol; 2007 Aug; 13(31):4192-8. PubMed ID: 17696247
[TBL] [Abstract][Full Text] [Related]
17. Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression.
Kawate S; Fukusato T; Ohwada S; Watanuki A; Morishita Y
Oncology; 1999; 57(2):157-63. PubMed ID: 10461064
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of c-myc gene without gene amplification in human hepatocellular carcinoma.
Wu B; Wang M; You W; Yang S
Chin Med J (Engl); 1996 Dec; 109(12):922-5. PubMed ID: 9275322
[TBL] [Abstract][Full Text] [Related]
19. [Overexpression of c-myc and p53 gene in human hepato-cellular carcinoma--a study with immunohistochemistry and in situ hybridization].
Yang S; Wang M; You W
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):415-7. PubMed ID: 8697990
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach.
Saegusa M; Takano Y; Kishimoto H; Wakabayashi G; Nohga K; Okudaira M
J Cancer Res Clin Oncol; 1993; 119(12):737-44. PubMed ID: 8104947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
